Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10

Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry (2010) 1.83

Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study. J Neurol Neurosurg Psychiatry (2006) 1.22

Abnormal kalirin signaling in neuropsychiatric disorders. Brain Res Bull (2013) 1.01

Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am J Geriatr Psychiatry (2011) 1.00

Psychosis in Alzheimer's disease. Biol Psychiatry (2013) 0.99

Management of the behavioral and psychological symptoms of dementia. Clin Interv Aging (2007) 0.94

Executive dysfunction in Alzheimer disease. Arch Neurol (2004) 0.94

The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis. Int Psychogeriatr (2008) 0.94

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease. Curr Neuropharmacol (2012) 0.93

β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging (2012) 0.91

Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr (2008) 0.88

Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. Am J Med Genet B Neuropsychiatr Genet (2007) 0.87

Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis. J Alzheimers Dis (2014) 0.87

Recognition and Management of Behavioral Disturbances in Dementia. Prim Care Companion J Clin Psychiatry (2001) 0.84

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2013) 0.82

Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtype. Int J Geriatr Psychiatry (2015) 0.80

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. Neuropsychiatr Dis Treat (2010) 0.79

Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities. Neurobiol Aging (2014) 0.79

Neuropsychiatric Symptoms in Mild Cognitive Impairment. Can J Psychiatry (2017) 0.79

Transdiagnostic Extension of Delusions: Schizophrenia and Beyond. Schizophr Bull (2017) 0.78

Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation. Cogn Behav Neurol (2008) 0.78

New wine in old bottle: late-life psychosis. Psychiatr Clin North Am (2011) 0.77

Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int J Geriatr Psychiatry (2013) 0.77

Behavioral disturbances in dementia. Dialogues Clin Neurosci (2003) 0.77

Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole. Clin Interv Aging (2008) 0.76

Longitudinal course of behavioural and psychological symptoms of dementia: systematic review. Br J Psychiatry (2016) 0.76

Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer's disease. Sci Rep (2016) 0.75

Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology (2000) 0.75

TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis. Int Psychogeriatr (2014) 0.75

Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates. J Alzheimers Dis (2015) 0.75

Optimal treatment of Alzheimer's disease psychosis: challenges and solutions. Neuropsychiatr Dis Treat (2014) 0.75

Medium range cognitive impairment (MeRCI) hypothesis for psychosis formation: evidence from epidemiological studies and recent molecular genetic developments. J Psychiatry Neurosci (2014) 0.75

Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease. J Clin Psychiatry (2016) 0.75

Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review. Biomed Res Int (2015) 0.75

Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies. Front Aging Neurosci (2017) 0.75

The sequence of the human genome. Science (2001) 101.55

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67

Changing provider behavior: an overview of systematic reviews of interventions. Med Care (2001) 17.89

Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 5.94

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull (2001) 5.89

Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technol Assess (2001) 5.84

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38

Symmetry and transitivity of conditional relations in monkeys (Cebus apella) and pigeons (Columba livia). J Exp Anal Behav (1985) 5.02

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1988) 4.77

A simplified acute physiology score for ICU patients. Crit Care Med (1984) 4.55

Boolean formalization of genetic control circuits. J Theor Biol (1973) 4.54

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 4.31

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA (2000) 3.99

Reduction of environmental tobacco smoke exposure among asthmatic children: a controlled trial. Chest (1994) 3.89

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79

A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74

Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61

Distance between homes and exercise facilities related to frequency of exercise among San Diego residents. Public Health Rep (1990) 3.57

The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53

Identification of group B streptococci by immunofluorescence staining. Appl Microbiol (1974) 3.51

Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40

Genetics and physiology of defective lysogeny in K12 (lambda): studies of early mutants. Virology (1966) 3.39

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38

Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med (1982) 3.30

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23

The fetal inflammatory response syndrome. Am J Obstet Gynecol (1998) 3.22

Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc (1999) 3.11

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07

Ethnic, socioeconomic, and sex differences in physical activity among adolescents. J Clin Epidemiol (1996) 3.06

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (1993) 2.96

Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther (1987) 2.92

A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86

Renal injury in the extremely obese patients with normal renal function. Kidney Int (2008) 2.83

A multimodal assessment of driving performance in HIV infection. Neurology (2004) 2.81

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74

Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci (1988) 2.73

A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med (1996) 2.66

Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol (1999) 2.65

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62

Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60

Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59

Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev (2006) 2.59

Thyroxine should be tried in clinically hypothyroid but biochemically euthyroid patients. BMJ (1997) 2.58

Late-onset schizophrenia: an overview. Schizophr Bull (1988) 2.58

Prevalence of primary glaucoma in an urban south Indian population. Indian J Ophthalmol (1998) 2.58

Social skills performance assessment among older patients with schizophrenia. Schizophr Res (2001) 2.53

A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest (1990) 2.52

The determination of low d5-phenylalanine enrichment (0.002-0.09 atom percent excess), after conversion to phenylethylamine, in relation to protein turnover studies by gas chromatography/electron ionization mass spectrometry. Rapid Commun Mass Spectrom (1992) 2.48

Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology (1984) 2.48

Discriminatory hCG zone: its use in the sonographic evaluation for ectopic pregnancy. Obstet Gynecol (1981) 2.48

Hydrogen-poor superluminous stellar explosions. Nature (2011) 2.48

Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc (1999) 2.47

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology (2002) 2.47

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45

The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med (1994) 2.39

Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol (2000) 2.37

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry (1988) 2.36

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology (2011) 2.35

Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol (2001) 2.35

Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31

An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2003) 2.31

Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol (2000) 2.30

Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol (1997) 2.30

A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30

Predictors of adoption and maintenance of vigorous physical activity in men and women. Prev Med (1992) 2.26

In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2007) 2.24

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol (1989) 2.23

Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol (2000) 2.21

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19

Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology (2005) 2.18

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med (1997) 2.15

Cognitive and functional status of the oldest old. J Am Geriatr Soc (1996) 2.14

Rehabilitation of hemiparesis after stroke with a mirror. Lancet (1999) 2.13

Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med (2000) 2.12

Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2. Neurology (1987) 2.11

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10